Literature DB >> 6441591

Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen.

I Ohkubo, K Kurachi, T Takasawa, H Shiokawa, M Sasaki.   

Abstract

A lambda gt11 cDNA library containing DNA inserts prepared from human liver mRNA has been screened with an antibody to human alpha 2-thiol proteinase inhibitor that was isolated from fresh plasma. Eighteen positive clones were isolated from one million phage, and each was plaque purified. The cDNA insert of one of these phage was sequenced and shown to code for alpha 2-thiol proteinase inhibitor as identified by a partial amino acid sequence of the light chain of alpha 2-thiol proteinase inhibitor. This cDNA insert contained 1529 base pairs coding for the complete alpha 2-thiol proteinase inhibitor. It included 45 base pairs of 5' noncoding sequence, 1281 base pairs that code for pre alpha 2-thiol proteinase inhibitor, a stop codon, 160 base pairs of 3' noncoding sequence, and 40 base pairs of poly(A) tail. The noncoding sequence on the 3' end contained a potential recognition site (AATAAA) for processing and polyadenylation of precursor messenger RNA. The amino acid sequence of alpha 2-thiol proteinase inhibitor deduced from the cDNA showed a striking similarity (overall homology at 74%) to that of bovine low molecular weight (LMW) kininogen, including two internally repeated sequences and a nonapeptide sequence of bradykinin. These data clearly indicated that alpha 2-thiol proteinase inhibitor and LMW kininogen are identical. This was further supported by immunological cross-reactivity between alpha 2-thiol proteinase inhibitor and LMW kininogen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441591     DOI: 10.1021/bi00319a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Evolution of proteins of the cystatin superfamily.

Authors:  N D Rawlings; A J Barrett
Journal:  J Mol Evol       Date:  1990-01       Impact factor: 2.395

2.  The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction.

Authors:  D Fong; D I Smith; W T Hsieh
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

Review 3.  The role of cystatins in tick physiology and blood feeding.

Authors:  Alexandra Schwarz; James J Valdés; Michalis Kotsyfakis
Journal:  Ticks Tick Borne Dis       Date:  2012-04-20       Impact factor: 3.744

4.  Kinetics of inhibition of platelet calpain II by human kininogens.

Authors:  H N Bradford; A H Schmaier; R W Colman
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

Review 5.  Friends and relations of the cystatin superfamily--new members and their evolution.

Authors:  W M Brown; K M Dziegielewska
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

6.  Internally repeated sequences in ras gene products.

Authors:  T Hiwasa
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

7.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

8.  Potential proteolytic activity of human plasma fibronectin.

Authors:  V Keil-Dlouha; T Planchenault
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

9.  Characterization by rapid-kinetic and equilibrium methods of the interaction between N-terminally truncated forms of chicken cystatin and the cysteine proteinases papain and actinidin.

Authors:  P Lindahl; M Nycander; K Ylinenjärvi; E Pol; I Björk
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

10.  Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes.

Authors:  Dusan Kordis; Vito Turk
Journal:  BMC Evol Biol       Date:  2009-11-18       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.